Sensing Opportunity Biotech firm Sava specializes in advanced biosensing technology that enables painless, real-time health data access. This presents a cross-sell opportunity for expanding biosensor deployment in clinical research, personalized medicine, and remote monitoring partnerships.

Clinical Collaboration With a focus on health information embedded under the skin, engage Sava for joint development or integration with clinical trials, particularly in CNS-related research where real-time biosensing can enhance patient monitoring and data quality.

Tech Stack Fit Sava already leverages cloud, data tools, and collaboration platforms (Google Cloud, MongoDB, DBT, Jira, Confluence). Propose cloud-based data analytics, secure data pipelines, and integration services to accelerate product development and regulatory-grade data management.

Growth Readiness Company size (51-200 employees) alongside recent public market activity around Cassava Sciences indicates growing visibility and potential need for scalable partnerships, pilot programs, and strategic alliances to accelerate commercialization.

Security & Governance Given use of 1Password and enterprise tools, position security-focused offerings such as compliant data sharing, access controls, and governance frameworks to support sensitive health data handling and regulatory compliance in collaborations.